NASDAQ:ADUS Addus HomeCare - ADUS Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Addus HomeCare Co. Please log in to your account or sign up in order to add this asset to your watchlist. $104.91 +1.96 (+1.90%) (As of 03/27/2023 12:00 AM ET) Add Compare Share Share Today's Range$102.13▼$105.8250-Day Range$97.94▼$112.2852-Week Range$73.65▼$114.99Volume91,335 shsAverage Volume92,283 shsMarket Capitalization$1.69 billionP/E Ratio36.81Dividend YieldN/APrice Target$113.00 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability Addus HomeCare MarketRank™ ForecastAnalyst RatingBuy3.00 Rating ScoreUpside/Downside7.7% Upside$113.00 Price TargetShort InterestBearish3.05% of Float Sold ShortDividend StrengthN/ASustainability-0.50Upright™ Environmental ScoreNews Sentiment0.85Based on 6 Articles This WeekInsider TradingSelling Shares$1.10 M Sold Last QuarterProj. Earnings Growth12.53%From $3.59 to $4.04 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.28 out of 5 starsMedical Sector370th out of 995 stocksHome Health Care Services Industry5th out of 9 stocks 1.5 Analyst's Opinion Consensus RatingAddus HomeCare has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 5 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $113.00, Addus HomeCare has a forecasted upside of 7.7% from its current price of $104.91.Amount of Analyst CoverageAddus HomeCare has only been the subject of 1 research reports in the past 90 days. Previous Next 2.0 Short Interest Percentage of Shares Shorted3.05% of the float of Addus HomeCare has been sold short.Short Interest Ratio / Days to CoverAddus HomeCare has a short interest ratio ("days to cover") of 5.5.Change versus previous monthShort interest in Addus HomeCare has recently increased by 10.56%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldAddus HomeCare does not currently pay a dividend.Dividend GrowthAddus HomeCare does not have a long track record of dividend growth. Previous Next 5.0 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreAddus HomeCare has received a 85.99% net impact score from Upright. The largest positive contribution comes from its "Meaning & joy" impact, which is mostly driven by its "Private hospice care", "Private occupational therapy services", and "Private home care for the elderly" products. See details.Environmental SustainabilityThe Environmental Impact score for Addus HomeCare is -0.50. Previous Next 3.8 News and Social Media Coverage News SentimentAddus HomeCare has a news sentiment score of 0.85. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.62 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 6 news articles for Addus HomeCare this week, compared to 2 articles on an average week.Search Interest6 people have searched for ADUS on MarketBeat in the last 30 days. MarketBeat Follows1 people have added Addus HomeCare to their MarketBeat watchlist in the last 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Addus HomeCare insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,099,123.00 in company stock.Percentage Held by InsidersOnly 4.50% of the stock of Addus HomeCare is held by insiders.Percentage Held by Institutions97.42% of the stock of Addus HomeCare is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 2.5 Earnings and Valuation Earnings GrowthEarnings for Addus HomeCare are expected to grow by 12.53% in the coming year, from $3.59 to $4.04 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Addus HomeCare is 36.81, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 125.78.Price to Earnings Ratio vs. SectorThe P/E ratio of Addus HomeCare is 36.81, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 153.15.Price to Earnings Growth RatioAddus HomeCare has a PEG Ratio of 2.46. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioAddus HomeCare has a P/B Ratio of 2.67. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Addus HomeCare (NASDAQ:ADUS) StockAddus HomeCare Corp. engages in the provision of in-home personal care services. It operates through the following segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living, primarily to persons who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill or disabled. The Hospice segment includes physical, emotional, and spiritual care for people who are terminally ill as well as for their families. The Home Health segment offers services that are primarily medical in nature to individuals who may require assistance during an illness or after surgery, and include skilled nursing and physical, occupational and speech therapy. The company was founded on July 27, 2006 and is headquartered in Frisco, TX.Read More Receive ADUS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Addus HomeCare and its competitors with MarketBeat's FREE daily newsletter. Email Address ADUS Stock News HeadlinesMarch 24, 2023 | finance.yahoo.comIs Addus HomeCare (ADUS) Stock Outpacing Its Medical Peers This Year?March 23, 2023 | nasdaq.comHere's Why You Should Retain HCA Healthcare (HCA) Stock NowMarch 28, 2023 | Tradewins (Ad)Modern Day Options Trading For Beginners!These days it takes more than willpower to succeed on Wall Street and for new traders, even small mistakes can sink an account! With "Your Guide To Successful Options Trading" by expert Wendy Kirkland, you can avoid new trader pitfalls and learn to earn in this vicious market. March 23, 2023 | finance.yahoo.com4 Promising Stocks From a Challenging Outpatient Home Health IndustryMarch 15, 2023 | finance.yahoo.comIs There Now An Opportunity In Addus HomeCare Corporation (NASDAQ:ADUS)?March 7, 2023 | finance.yahoo.comIs Addus HomeCare (ADUS) Outperforming Other Medical Stocks This Year?March 6, 2023 | finance.yahoo.comWhat Makes Addus HomeCare (ADUS) a New Buy StockMarch 1, 2023 | finance.yahoo.comQ4 2022 Addus Homecare Corp Earnings CallMarch 28, 2023 | Tradewins (Ad)Modern Day Options Trading For Beginners!These days it takes more than willpower to succeed on Wall Street and for new traders, even small mistakes can sink an account! With "Your Guide To Successful Options Trading" by expert Wendy Kirkland, you can avoid new trader pitfalls and learn to earn in this vicious market. March 1, 2023 | finance.yahoo.comAddus HomeCare Full Year 2022 Earnings: In Line With ExpectationsMarch 1, 2023 | finance.yahoo.comAddus HomeCare Names Heather Dixon to Board of DirectorsFebruary 28, 2023 | finance.yahoo.comAddus HomeCare to Participate in Oppenheimer 33rd Annual Healthcare ConferenceFebruary 27, 2023 | finance.yahoo.comAddus HomeCare (ADUS) Q4 Earnings and Revenues Beat EstimatesFebruary 27, 2023 | msn.comAddus HomeCare Non-GAAP EPS of $1.11 beats by $0.15, revenue of $247.1M beats by $0.92MFebruary 27, 2023 | finance.yahoo.comAddus HomeCare Announces Fourth Quarter and Year End 2022 Financial ResultsFebruary 25, 2023 | seekingalpha.comADUS Addus HomeCare CorporationFebruary 24, 2023 | msn.comAddus HomeCare's Earnings: A PreviewFebruary 22, 2023 | finance.yahoo.comAddus HomeCare to Participate in Raymond James 44th Annual Institutional Investors ConferenceFebruary 20, 2023 | finance.yahoo.comAddus HomeCare (ADUS) Reports Next Week: What to ExpectFebruary 13, 2023 | finance.yahoo.comAddus HomeCare Announces Fourth Quarter and Year-End 2022 Earnings Release and Conference CallFebruary 12, 2023 | finance.yahoo.comAddus HomeCare (NASDAQ:ADUS) Will Want To Turn Around Its Return TrendsJanuary 24, 2023 | finance.yahoo.comDo Addus HomeCare's (NASDAQ:ADUS) Earnings Warrant Your Attention?December 30, 2022 | finance.yahoo.comZacks Industry Outlook Highlights Option Care Health, LifeStance Health, Addus HomeCare and PennantDecember 16, 2022 | finance.yahoo.comThose who invested in Addus HomeCare (NASDAQ:ADUS) five years ago are up 202%November 28, 2022 | stocknews.comCathie Wood Just Bought This Stock for Under $5. Should You?November 27, 2022 | seekingalpha.comAddus HomeCare: Reaffirm Buy On Valuation, Future Value CreationNovember 24, 2022 | benzinga.comMassive Insider Trade At Addus HomeCareSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive ADUS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Addus HomeCare and its competitors with MarketBeat's FREE daily newsletter. Email Address ADUS Company Calendar Last Earnings10/31/2021Today3/27/2023Next Earnings (Estimated)5/01/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Home health care services Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:ADUS CUSIPN/A CIK1468328 Webwww.addus.com Phone(469) 535-8200Fax630-487-2707Employees33,182Year FoundedN/APrice Target and Rating Average Stock Price Forecast$113.00 High Stock Price Forecast$130.00 Low Stock Price Forecast$101.00 Forecasted Upside/Downside+7.7%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)$2.85 Trailing P/E Ratio36.81 Forward P/E Ratio29.22 P/E Growth2.46Net Income$46.03 million Net Margins4.84% Pretax Margin6.33% Return on Equity8.58% Return on Assets5.44% Debt Debt-to-Equity Ratio0.21 Current Ratio1.70 Quick Ratio1.70 Sales & Book Value Annual Sales$951.12 million Price / Sales1.78 Cash Flow$4.25 per share Price / Cash Flow24.71 Book Value$39.33 per share Price / Book2.67Miscellaneous Outstanding Shares16,130,000Free Float15,402,000Market Cap$1.69 billion OptionableOptionable Beta0.82 Key ExecutivesR. Dirk AllisonChairman & Chief Executive OfficerW. Bradley BickhamPresident & Chief Operating OfficerBrian W. PoffCFO, Secretary, Treasurer & Executive VPNick DuthieVice President-Information TechnologyMichael WattenbargerChief Information Officer & Executive VPKey CompetitorsAdaptHealthNASDAQ:AHCOAmedisysNASDAQ:AMEDEnhabitNYSE:EHABLHC GroupNASDAQ:LHCGOption Care HealthNASDAQ:OPCHView All CompetitorsInsiders & InstitutionsMetLife Investment Management LLCBought 157 shares on 3/23/2023Ownership: 0.050%Michael D WattenbargerSold 244 sharesTotal: $26,049.44 ($106.76/share)Voya Investment Management LLCSold 19,112 shares on 2/28/2023Ownership: 0.085%R Dirk AllisonSold 1,794 sharesTotal: $186,845.10 ($104.15/share)W Bradley BickhamSold 659 sharesTotal: $68,634.85 ($104.15/share)View All Insider TransactionsView All Institutional Transactions ADUS Stock - Frequently Asked Questions Should I buy or sell Addus HomeCare stock right now? 5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Addus HomeCare in the last year. There are currently 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ADUS shares. View ADUS analyst ratings or view top-rated stocks. What is Addus HomeCare's stock price forecast for 2023? 5 equities research analysts have issued 12-month target prices for Addus HomeCare's shares. Their ADUS share price forecasts range from $101.00 to $130.00. On average, they anticipate the company's share price to reach $113.00 in the next twelve months. This suggests a possible upside of 7.7% from the stock's current price. View analysts price targets for ADUS or view top-rated stocks among Wall Street analysts. How have ADUS shares performed in 2023? Addus HomeCare's stock was trading at $99.49 at the beginning of 2023. Since then, ADUS stock has increased by 5.4% and is now trading at $104.91. View the best growth stocks for 2023 here. Are investors shorting Addus HomeCare? Addus HomeCare saw a increase in short interest in the month of March. As of March 15th, there was short interest totaling 482,700 shares, an increase of 10.6% from the February 28th total of 436,600 shares. Based on an average daily volume of 88,100 shares, the short-interest ratio is currently 5.5 days. Approximately 3.1% of the company's shares are short sold. View Addus HomeCare's Short Interest. When is Addus HomeCare's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, May 1st 2023. View our ADUS earnings forecast. How were Addus HomeCare's earnings last quarter? Addus HomeCare Co. (NASDAQ:ADUS) issued its quarterly earnings results on Sunday, October, 31st. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.89 by $0.02. The business earned $216.66 million during the quarter, compared to analyst estimates of $227.11 million. Addus HomeCare had a trailing twelve-month return on equity of 8.58% and a net margin of 4.84%. Addus HomeCare's quarterly revenue was up 11.7% compared to the same quarter last year. During the same period in the prior year, the company earned $0.69 earnings per share. What ETFs hold Addus HomeCare's stock? ETFs with the largest weight of Addus HomeCare (NASDAQ:ADUS) stock in their portfolio include Argent Mid Cap ETF (AMID), Invesco S&P SmallCap Health Care ETF (PSCH), SPDR S&P Health Care Services ETF (XHS), Janus Henderson Small Cap Growth Alpha ETF (JSML), Invesco S&P SmallCap Momentum ETF (XSMO), Invesco S&P SmallCap 600 Pure Growth ETF (RZG), iShares U.S. Healthcare Providers ETF (IHF) and Vanguard S&P Small-Cap 600 Growth ETF (VIOG). What is Dirk Allison's approval rating as Addus HomeCare's CEO? 91 employees have rated Addus HomeCare Chief Executive Officer Dirk Allison on Glassdoor.com. Dirk Allison has an approval rating of 51% among the company's employees. This puts Dirk Allison in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Addus HomeCare own? Based on aggregate information from My MarketBeat watchlists, some companies that other Addus HomeCare investors own include AbbVie (ABBV), Bank of America (BAC), Bristol-Myers Squibb (BMY), Gilead Sciences (GILD), Verizon Communications (VZ), CVS Health (CVS), Pfizer (PFE), Ulta Beauty (ULTA), Cisco Systems (CSCO) and Walt Disney (DIS). What is Addus HomeCare's stock symbol? Addus HomeCare trades on the NASDAQ under the ticker symbol "ADUS." Who are Addus HomeCare's major shareholders? Addus HomeCare's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Morgan Stanley (5.63%), Silvercrest Asset Management Group LLC (4.68%), Principal Financial Group Inc. (3.85%), Dimensional Fund Advisors LP (3.75%), WCM Investment Management LLC (3.19%) and Price T Rowe Associates Inc. MD (2.38%). Insiders that own company stock include Brian Poff, Darby Anderson, David W Tucker, Esteban Lopez, Laurie Manning, Mark L First, Michael D Wattenbarger, R Dirk Allison, Roberton James Stevenson, Sean Gaffney and W Bradley Bickham. View institutional ownership trends. How do I buy shares of Addus HomeCare? Shares of ADUS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Addus HomeCare's stock price today? One share of ADUS stock can currently be purchased for approximately $104.91. How much money does Addus HomeCare make? Addus HomeCare (NASDAQ:ADUS) has a market capitalization of $1.69 billion and generates $951.12 million in revenue each year. The company earns $46.03 million in net income (profit) each year or $2.85 on an earnings per share basis. How many employees does Addus HomeCare have? The company employs 33,182 workers across the globe. How can I contact Addus HomeCare? Addus HomeCare's mailing address is 6801 GAYLORD PARKWAY, FRISCO TX, 75034. The official website for the company is www.addus.com. The company can be reached via phone at (469) 535-8200, via email at investorrelations@addus.com, or via fax at 630-487-2707. This page (NASDAQ:ADUS) was last updated on 3/28/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.